KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Cvs Health's Consolidated Net Income rose 8009.86% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year decrease of 6232.01%. This contributed to the annual value of $1.7 billion for FY2025, which is 6232.01% down from last year.
  • Latest data reveals that Cvs Health reported Consolidated Net Income of $2.9 billion as of Q4 2025, which was up 8009.86% from -$4.0 billion recorded in Q3 2025.
  • Cvs Health's Consolidated Net Income's 5-year high stood at $3.0 billion during Q2 2022, with a 5-year trough of -$4.0 billion in Q3 2025.
  • Over the past 5 years, Cvs Health's median Consolidated Net Income value was $1.8 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Per our database at Business Quant, Cvs Health's Consolidated Net Income surged by 16663.72% in 2023 and then tumbled by 571971.83% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Consolidated Net Income stood at $1.4 billion in 2021, then surged by 68.13% to $2.3 billion in 2022, then fell by 12.22% to $2.0 billion in 2023, then fell by 20.71% to $1.6 billion in 2024, then surged by 80.1% to $2.9 billion in 2025.
  • Its Consolidated Net Income stands at $2.9 billion for Q4 2025, versus -$4.0 billion for Q3 2025 and $1.0 billion for Q2 2025.